Pharmacological conversion of recent-onset atrial fibrillation: A systematic review

References

• Noc M, Stajer D, Horvat M. Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm. Am J Cardiol. 1990;65: 679–80.
   PubMed Web of Science ®Google Scholar
• Capucci A, Lenzi T, Boriani G, Trisolino G, Binetti N, Cavazza M, . Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol. 1992;70:69–72.
   PubMed Web of Science ®Google Scholar
• Hou ZY, Chang MS, Chen CY, Tu MS, Lin SL, Chiang HT, Woosley RL. Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study. Eur Heart J. 1995;16:521–8.
   PubMed Web of Science ®Google Scholar
• Donovan KD, Power BM, Hockings BE, Dobb GJ, Lee KY. Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. Am J Cardiol. 1995;75:693–7.
   PubMed Web of Science ®Google Scholar
• Galve E, Rius T, Ballester R, Artaza MA, Arnau JM, García-Dorado D, Soler-Soler J. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol. 1996; 27:1079–82.
   PubMed Web of Science ®Google Scholar
• Boriani G, Biffi M, Capucci A, Botto G, Broffoni T, Ongari M, . Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols. Pacing Clin Electrophysiol. 1998;21:2470–4.
   PubMed Web of Science ®Google Scholar
• Kochiadakis GE, Igoumenidis NE, Simantirakis EN, Marketou ME, Parthenakis FI, Mezilis NE, Vardas PE. Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: a placebo-controlled study. Pacing Clin Electrophysiol. 1998;21:2475–9.
   PubMed Web of Science ®Google Scholar
• Cotter G, Blatt A, Kaluski E, Metzkor-Cotter E, Koren M, Litinski I, . Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study. Eur Heart J. 1999;20:1833–42.
   PubMed Web of Science ®Google Scholar
• Peuhkurinen K, Niemelä M, Ylitalo A, Linnaluoto M, Lilja M, Juvonen J. Effectiveness of amiodarone as a single oral dose for recent-onset atrial fibrillation. Am J Cardiol. 2000;85:462–5.
   PubMed Web of Science ®Google Scholar
• Vardas PE, Kochiadakis GE, Igoumenidis NE, Tsatsakis AM, Simantirakis EN, Chlouverakis GI. Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study. Chest. 2000;117:1538–45.
   PubMed Web of Science ®Google Scholar
• Cybulski J, Kułakowski P, Budaj A, Danielewicz H, Maciejewicz J, Kawka-Urbanek T, Ceremuzyński L. Intravenous amiodarone for cardioversion of recent-onset atrial fibrillation. Clin Cardiol. 2003;26:329–35.
   PubMed Web of Science ®Google Scholar
• Thomas SP, Guy D, Wallace E, Crampton R, Kijvanit P, Eipper V, . Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial. Am Heart J. 2004; 147:E3.
   PubMed Web of Science ®Google Scholar
• Kochiadakis GE, Igoumenidis NE, Hamilos ME, Marketou ME, Chlouverakis GI, Vardas PE. A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation. Am J Cardiol. 2007;99:1721–5.
   PubMed Web of Science ®Google Scholar
• Falk RH, Knowlton AA, Bernard SA, Gotlieb NE, Battinelli NJ. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial. Ann Intern Med. 1987;106:503–6.
   PubMed Web of Science ®Google Scholar
• Jordaens L, Trouerbach J, Calle P, Tavernier R, Derycke E, Vertongen P, . Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo. Eur Heart J. 1997;18:643–8.
   PubMed Web of Science ®Google Scholar
• The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group. Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. Eur Heart J. 1997;18:649–54.
   PubMed Web of Science ®Google Scholar
• Bianconi L, Mennuni M, PAFIT-3 Investigators. Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. Am J Cardiol. 1998;82:584–8.
   PubMed Web of Science ®Google Scholar
• Chiladakis JA, Stathopoulos C, Davlouros P, Manolis AS. Intravenous magnesium sulfate versus diltiazem in paroxysmal atrial fibrillation. Int J Cardiol. 2001;79:287–91.
   PubMed Web of Science ®Google Scholar
• Boudonas G, Lefkos N, Efthymiadis AP, Styliadis IG, Tsapas G. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias. Acta Cardiol. 1995;50:125–34.
   PubMed Web of Science ®Google Scholar
• Donovan KD, Dobb GJ, Coombs LJ, Lee KY, Weekes JN, Murdock CJ, Clarke GM. Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide. Am J Cardiol. 1991;67:137–41.
   PubMed Web of Science ®Google Scholar
• Reisinger J, Gatterer E, Heinze G, Wiesinger K, Zeindlhofer E, Gattermeier M, . Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation. Am J Cardiol. 1998;81:1450–4.
   PubMed Web of Science ®Google Scholar
• Stambler BS, Wood MA, Ellenbogen KA, Perry KT, Wakefield LK, VanderLugt JT. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation. 1996;94:1613–21.
   PubMed Web of Science ®Google Scholar
• Reisinger J, Gatterer E, Lang W, Vanicek T, Eisserer G, Bachleitner T, . Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset. Eur Heart J. 2004;25:1318–24.
   PubMed Web of Science ®Google Scholar
• Atarashi H, Inoue H, Hiejima K, Hayakawa H,. The PSTAF Investigators Conversion of recent-onset Atrial Fibrillation by a single oral dose of Pilsicainide. Am J Cardiol. 1996;78:694–7.
   PubMed Web of Science ®Google Scholar
• Kochiadakis GE, Igoumenidis NE, Simantirakis EN, Marketou ME, Parthenakis FI, Mezilis NE, Vardas PE. Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: a placebo-controlled study. Pacing Clin Electrophysiol. 1998;21:2475–9.
   PubMed Web of Science ®Google Scholar
• Madrid AH, Moro C, Marín-Huerta E, Mestre JL, Novo L, Costa A. Comparison of flecainide and procainamide in cardioversion of atrial fibrillation. Eur Heart J. 1993;14: 1127–31.
   PubMed Web of Science ®Google Scholar
• Boriani G, Capucci A, Lenzi T, Sanguinetti M, Magnani B. Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration. Chest. 1995;108:355–8.
   PubMed Web of Science ®Google Scholar
• Fresco C, Proclemer A, Pavan A, Buia G, Vicentini A, Pavan D, Morgera T. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Clin Cardiol. 1996;19: 409–12.
   PubMed Web of Science ®Google Scholar
• Bellandi F, Dabizzi RP, Cantini F, Natale MD, Niccoli L. Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study. Cardiovasc Drugs Ther. 1996;10:153–7.
   PubMed Web of Science ®Google Scholar
• Botto GL, Capucci A, Bonini W, Boriani G, Broffoni T, Barone P, . Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens. Int J Cardiol. 1997;58:55–61.
   PubMed Web of Science ®Google Scholar
• Boriani G, Biffi M, Capucci A, Botto GL, Broffoni T, Rubino I, . Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. Ann Intern Med. 1997;126:621–5.
   PubMed Web of Science ®Google Scholar
• Azpitarte J, Alvarez M, Baún O, García R, Moreno E, Martín F, . Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study. Eur Heart J. 1997;18:1649–54.
   PubMed Web of Science ®Google Scholar
• Ganau G, Lenzi T. Intravenous propafenone for converting recent onset atrial fibrillation in emergency departments: a randomized placebo-controlled multicenter trial. J Emerg Med. 1998;16:383–7.
   PubMedGoogle Scholar
• Botto GL, Bonini W, Broffoni T, Espureo M, Cappelletti G, Lombardi R, . Randomized, crossover, controlled comparison of oral loading versus intravenous infusion of propafenone in recent-onset atrial fibrillation. Pacing Clin Electrophysiol. 1998;21:2480–4.
   PubMed Web of Science ®Google Scholar
• Capucci A, Boriani G, Rubino I, Della Casa S, Sanguinetti M, Magnani B. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol. 1994;43:305–13.
   PubMed Web of Science ®Google Scholar
• Capucci A, Villani GQ, Aschieri D, Piepoli M. Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study. Int J Cardiol. 1999;68:187–96. Erratum in: Int J Cardiol 1999;70:213.
   PubMed Web of Science ®Google Scholar
• Halinen MO, Huttunen M, Paakkinen S, Tarssanen L. Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm. Am J Cardiol. 1995;76:495–8.
   PubMed Web of Science ®Google Scholar
• Sung RJ, Tan HL, Karagounis L, Hanyok JJ, Falk R, Platia E, . Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Am Heart J. 1995;129:739–48.
   PubMed Web of Science ®Google Scholar
• Suttorp MJ, Kingma JH, Lie-A-Huen L, Mast EG. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am J Cardiol. 1989;63:693–6.
   PubMed Web of Science ®Google Scholar
• Kondili A, Kastrati A, Popa Y. Comparative evaluation of verapamil, flecainide and propafenone for the acute conversion of atrial fibrillation to sinus rhythm. Wien Klin Wochenschr. 1990;102:510–3.
   PubMed Web of Science ®Google Scholar
• Platia EV, Michelson EL, Porterfield JK, Das G. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. Am J Cardiol. 1989;63:925–9.
   PubMed Web of Science ®Google Scholar
• Roy D, Rowe BH, Stiell IG, Coutu B, Ip JH, Phaneuf D, . A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation. J Am Coll Cardiol. 2004;44: 2355–61.
   PubMed Web of Science ®Google Scholar
• Roy D, Pratt CM, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, . Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo- controlled trial. Circulation. 2008;117:1518–25.
   PubMed Web of Science ®Google Scholar
• Pratt CM, Roy D, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, . Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation. Am J Cardiol. 2010;106:1277–83.
   PubMed Web of Science ®Google Scholar
• Camm AJ, Capucci A, Hohnloser SH, Torp-Pedersen C, Van Gelder IC, Mangal B, . A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. J Am Coll Cardiol. 2011;57:313–21.
   PubMed Web of Science ®Google Scholar
• Alboni P, Botto GL, Baldi N, Luzi M, Russo V, Gianfranchi L, . Outpatient treatment of recent-onset atrial fibrillation with the “pill-in-the-pocket” approach. N Engl J Med. 2004;351:2384–91.
   PubMed Web of Science ®Google Scholar
• Alboni P, Botto GL, Boriani G, Russo G, Pacchioni F, Iori M, . Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during ‘pill-in-the-pocket’ treatment. Heart. 2010;96:546–9.
   PubMed Web of Science ®Google Scholar